Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
NOT YET RECRUITING
NCT07577479
PHASE1
A Phase 1 Study of Single-Dose BW-50218 in Healthy Chinese Participants
Sponsor: Shanghai Argo Biopharmaceutical Co., Ltd.
View on ClinicalTrials.gov
Summary
A Phase 1 Study of Single-Dose BW-50218 in Healthy Chinese Participants
Official title: A Phase 1 Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of A Single Dose of BW-50218 in Healthy Chinese Participants
Key Details
Gender
All
Age Range
18 Years - 60 Years
Study Type
INTERVENTIONAL
Enrollment
24
Start Date
2026-05-15
Completion Date
2028-04-30
Last Updated
2026-05-11
Healthy Volunteers
Yes
Conditions
Interventions
DRUG
BW-50218 Injection
Solution for injection
DRUG
Saline (0.9% NaCl)
Solution for injection
Locations (1)
Argo Investigative Site
Shanghai, China